The new vaccine will be offered to adults 18 year’s of age and older, and youth from 12-17 year’s of age who are at higher risk of developing serious illness from COVID-19.
Dr. Danuta Skowronski is the lead author of the study, which showed largest percentage increase overe the past 12 months was among those 19 years of age and younger.
